12.09.2023 Ebersberg, Deutschland
Eurofins Genomics is thrilled to announce its strategic initiative with Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK). This
partnership aims to enrich our offerings in research, population health, and regulated clinical trials through the integration of Olink technology.